Coherus BioSciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $54,144 | $70,774 | $64,979 | $77,063 |
Gross Profit | 20,286 | 50,033 | 35,424 | 40,970 |
EBITDA | -44,317 | -3,840 | -6,400 | -30,418 |
EBIT | -45,350 | -5,389 | -7,587 | -31,925 |
Net Income | -50,696 | -10,751 | -12,921 | 102,875 |
Net Change In Cash | 54,144 | 70,774 | 64,979 | 77,063 |
Free Cash Flow | 28,608 | -62,016 | 59,734 | -46,766 |
Cash | 125,987 | 97,690 | 159,240 | 259,774 |
Basic Shares | 115,418 | 115,210 | 114,819 | 125,529 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $266,960 | $257,244 | $211,042 | $326,551 |
Gross Profit | 149,407 | 94,461 | 140,959 | 268,960 |
EBITDA | 60,941 | -193,939 | -255,581 | -260,687 |
EBIT | 55,665 | -197,730 | -259,280 | -266,348 |
Net Income | 28,507 | -237,892 | -326,628 | -306,322 |
Net Change In Cash | 266,960 | 257,244 | 211,042 | 326,551 |
Cost of Revenue | -353,648 | -123,963 | ||
Free Cash Flow | -20,440 | -175,170 | -243,163 | -38,721 |
Cash | 125,987 | 102,891 | 63,547 | 417,195 |
Basic Shares | 114,830 | 94,162 | 77,630 | 75,449 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.28 |
2024-09-30 | -$0.01 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.32 |
